Sales and Marketing

Showing 15 posts of 11526 posts found.

DConnelly

GSK’s Deidre Connelly named Woman of the Year

February 25, 2010 Sales and Marketing GlaxoSmithKline, HBA, appointment, sales and marketing

The Healthcare Businesswomen’s Association has named Deidre Connelly its 2010 Woman of the Year. Connelly is president of North America …

New starters at Double Helix

February 25, 2010 Sales and Marketing Double Helix, appointment, sales and marketing

Healthcare consultancy Double Helix has appointed Amanda Siebols (pictured) as a research consultant and Ioanna Maraki as a research executive. …
President Obama

Obama ‘closer than ever’ to health reform

February 25, 2010 Sales and Marketing Obama, US healthcare

The continuing showdown over health insurance reform in the US reaches its next potential flashpoint today (Thursday) with what is …

NICE approves Yondelis

February 24, 2010 Sales and Marketing NICE, PharmaMar, Yondelis

Cancer drug Yondelis has been approved by NICE for use on the NHS, but only after the manufacturer offered to …
IcahnWebV

Predatory Icahn moves in on weakened Genzyme

February 23, 2010 Research and Development, Sales and Marketing Gaucher, Genzyme, Icahn

Corporate raider Carl Icahn has made a bid to gain control of beleaguered Genzyme as it struggles to overcome major …
Avandia

Reports raise fresh Avandia safety questions

February 23, 2010 Research and Development, Sales and Marketing Avandia, GlaxoSmithKline, diabetes

GlaxoSmithKline’s troubled diabetes drug Avandia has been hit by fresh reports from the US that it increases the risk of …

Lilly UK appoints Ramona Sequeira managing director

February 23, 2010 Research and Development, Sales and Marketing appointment, lilly, research and development, sales and marketing

Lilly UK has appointed Ramona Sequeira managing director, UK and Republic of Ireland.She replaces Andrew Hotchkiss who becomes vice president …
Shire's Adderall

Low Adderall sales hit Shire

February 22, 2010 Sales and Marketing 2009 financials, Adderall, Shire

Shire has posted negative growth due to generic competition for its flagship ADHD drug Adderall XR. Product sales were down …
Brain picture

Novartis gains edge in MS treatment race

February 22, 2010 Research and Development, Sales and Marketing Cladribine, Gilenia, MS, Novartis

Novartis’ new oral multiple sclerosis treatment Gilenia will be given a priority review by the FDA.This could lead to a …

Sanofi’s Humenza poised to be Europe’s fifth swine flu vaccine

February 22, 2010 Sales and Marketing Sanofi Pasteur, Tyverb, Zeftera, swine flu

Sanofi Pasteur’s Humenza is set to become the fifth swine flu vaccine in Europe after gaining the support of a …

77 million Europeans fuelling counterfeits market

February 19, 2010 Sales and Marketing Europe, Pfizer, counterfeits

A new survey commissioned by Pfizer shows that Europeans are fuelling a counterfeit medicines market worth €10.5 billion.The findings are …
Tracleer1

Tracleer continues to fuel Actelion growth

February 19, 2010 Sales and Marketing Actelion, Tracleer

Actelion has posted a 20% increase in revenue on the strength of its pulmonary hypertension treatment Tracleer. The drug saw …

Rituxan gains approval for most common leukaemia

February 19, 2010 Sales and Marketing FDA, MabThera, Rituxan, blood cancer

Roche’s blockbuster cancer treatment MabThera/Rituxan has been approved by the FDA for the treatment of adult leukaemia. The drug earned …

Wyeth’s Dr Graham Cook joins British Pharmacopoeia Commission

February 18, 2010 Research and Development, Sales and Marketing Wyeth Pharmaceuticals, appointment, research and development, sales and marketing

Dr Graham Cook, a senior director in the Global Quality and Compliance division of Wyeth Pharmaceuticals, has joined the British …

Merger boosts Merck’s revenue

February 17, 2010 Sales and Marketing MA, Merck

Merck’s merger with Schering-Plough in October has helped boost the company’s full year sales by 13% to $27.4 billion.The gain …
The Gateway to Local Adoption Series

Latest content